Swiss start-up Noema raises $59m to develop neurology drugs offloaded by RocheSwiss biotech Noema has raised 54 million Swiss francs ($59m) to develop four neurological disorder drugs licensed in Share XSwiss start-up Noema raises $59m to develop neurology drugs offloaded by Rochehttps://pharmaphorum.com/news/swiss-start-up-noema-raises-59m-to-develop-neurology-drugs-offloaded-by-roche/